Peregrine Pharma (PPHM) Posts Q1 Loss of $0.14, Misses Views
Peregrine Pharmaceuticals (Nasdaq: PPHM) reports Q1 loss of $0.14, versus the analyst estimate of ($0.11). Revenue for the quarter was $3.21 million, which compares to the estimate of $5.83 million.
You May Also Be Interested In
- Iconix Brand Group, Inc. (ICON) Tops Q2 EPS by 8c; Boosts FY14 Outlook
- S&T Bancorp, Inc. (STBA) Tops Q2 EPS by 5c
- AK Steel Holding Corp. (AKS) Tops Q2 EPS by 6c
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!